Pharmacognosy intro
Jasminum grandiflorum L. and Jasminum sambac (L.) Aiton (Oleaceae), known as Royal Jasmine and Arabian Jasmine respectively, yield an absolute from flowers via solvent extraction. No true essential oil exists, as the flowers are too delicate for steam distillation. The major volatile compounds include benzyl acetate (18-28%), benzyl benzoate (14-21%), linalool (3-8%), indole (2.5%), and cis-jasmone (3%), alongside methyl jasmonate, eugenol, geraniol, and farnesol. Whole-plant flavonoids include rutin, kaempferol, and oleuropein. Linalool provides anxiolytic activity via voltage-gated sodium channel blockade and 5-HT1A receptor modulation. Benzyl acetate, the primary fragrance compound, exerts CNS effects through the olfactory-limbic pathway with sedative properties demonstrated in animal models. Indole acts as a trace amine receptor agonist, producing paradoxical effects: stimulating at low concentrations, sedating at higher exposure. This duality underlies jasmine's classification as both euphoric and calming. Methyl jasmonate, a plant stress hormone, demonstrates anti-inflammatory activity and induces apoptosis in cancer cell lines (IC50 ranging from 0.5-3.0 mM in leukemia models). Human clinical trial data for jasmine remains limited compared to other aromatherapy oils. Most evidence is preclinical. J. grandiflorum methanolic extract (100-400 mg/kg oral) showed dose-dependent anticonvulsant properties in both MES and PTZ seizure models in mice, comparable to diphenylhydantoin and sodium valproate (Patil & Saini, 2012). At 200 mg/kg in the elevated plus maze, J. grandiflorum extract increased open arm visits comparably to diazepam 2 mg/kg. J. sambac ethanolic floral extract (200-400 mg/kg) demonstrated cholinergic protective activity and improved learning and memory in scopolamine-induced amnesia models (Gupta & Kulshreshtha, 2018). Intraperitoneal administration of J. officinale flower extract caused dose-dependent CNS depression in mice within 15 minutes to 2 hours, suppressing aggressive behavior at 25-100 mg/kg and prolonging pentobarbitone-induced sleep (Elisha et al., 2008). The paradoxical stimulant-sedative duality, mediated through the interplay of indole at trace levels and the broader sedative volatile profile, represents jasmine's most distinctive pharmacological feature (reviewed in Rescigno et al., 2025, Food Frontiers).